ASCO Election
ASCO Election
Related Articles
A Preview of ‘Going Beyond RECIST: Radiomics in Kidney Cancer’
Dr. Zakharia will be chairing “Going Beyond RECIST: Radiomics in Kidney Cancer” at IKCS 2024. Here is a preview of the event.
Paper: Ibrutinib-Rituximab Is Superior to Rituximab-Chemotherapy in Previously Untreated Older Mantle Cell Lymphoma Patients: Results from the International Randomised Controlled Trial, Enrich
Program: Oral and Poster Abstracts Type: Oral Session: 623. Mantle Cell, Follicular, Waldenstrom’s, and Other Indolent B Cell Lymphomas: Clinical and Epidemiological: Therapies for Mantle…
Paper: Tolerability and Efficacy of Post-Transplant Cyclophosphamide in Older Adults Undergoing Matched Sibling Donor Allogeneic Transplantation: A Retrospective Analysis
Program: Oral and Poster Abstracts Session: 721. Allogeneic Transplantation: Conditioning Regimens, Engraftment, and Acute Toxicities: Poster III Hematology Disease Topics & Pathways: Research, Clinical Research,…
Paper: Superiority of Post-Transplant Cyclophosphamide-Based Graft Versus Host Disease (GvHD) Prophylaxis in Patients 70 Years and Older: A BMT CTN 1703 Post-Hoc Analysis
Program: Oral and Poster Abstracts Type: Oral Session: 722. Allogeneic Transplantation: Acute and Chronic GVHD and Immune Reconstitution: Avoiding GVHD and Improving Outcomes Hematology Disease…
Close icon
Panelist Scott Jennings says Peanut the squirrel, a social media star that was seized and euthanized by authorities, deserves justice.
State of Geographic Access to Cancer Treatment Trials in the United States: Are Studies Located Where Patients Live? | JCO Oncology Practice
PURPOSEIn this study, we describe the geographic distribution of US cancer treatment trials to identify disparities and opportunities for targeted improvements in access to research…
Instituto Catalán de Oncología, ICO – Hospitalet
SEHH – Sociedad Española de Hematología y Hemoterapia
Consultants respond to “highly misleading” BBC report on overtime pay – BMA media centre – BMA
Press release from the BMA
Paper: Impact of Clonal Heterogeneity in Newly Diagnosed, Transplant-Eligible Multiple Myeloma – Subgroup Analysis of the GMMG HD6 Phase III Trial
Program: Oral and Poster Abstracts Type: Oral Session: 653. Multiple Myeloma: Clinical and Epidemiological: Decluttering Responses and Dynamic Risk: How Can We Improve Prognostication in…
